BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
Yuxiang Ma(Sun Yat-sen University), Yan Huang(Sun Yat-sen University), Yuanyuan Zhao(Sun Yat-sen University), Shen Zhao(Sun Yat-sen University), Jinhui Xue(Sun Yat-sen University), Yunpeng Yang(Sun Yat-sen University), Wen‐Feng Fang(Sun Yat-sen University), Ye Guo(Shanghai East Hospital), Yaqian Han(Hunan Cancer Hospital), Kunyu Yang(Union Hospital), Yongsheng Li(Chongqing University), Jun Yang(Second Affiliated Hospital of Guangzhou Medical University), Zhenming Fu(Wuhan University), Gang Chen(Sun Yat-sen University), Likun Chen(Sun Yat-sen University), Ningning Zhou(Sun Yat-sen University), Ting Zhou(Sun Yat-sen University), Yaxiong Zhang(Sun Yat-sen University), Huaqiang Zhou(Sun Yat-sen University), Qianwen Liu(Sun Yat-sen University), Yi Zhu, Hai Zhu, Sa Xiao, Li Zhang(Sun Yat-sen University), Hongyun Zhao(Sun Yat-sen University)
Cited by 116
Abstract
Related Papers
No related papers found
Powered by citation graph analysis